To The Moon

Log In/Sign Up

ARKG Investment Tracker

Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·07:11
      ARKG Investment Tracker position change: Decreased position in Vertex Pharmaceuticals by 252 shares, the number of shares held decreased 0.92% compared to the previous period and now represents 1.08% of the total position.
      39Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:11
      ARKG Investment Tracker position change: Decreased position in Recursion Pharmaceuticals, Inc. by 56,254 shares, the number of shares held decreased 0.45% compared to the previous period and now represents 6.62% of the total position.
      279Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:11
      ARKG Investment Tracker position change: Decreased position in Moderna, Inc. by 286 shares, the number of shares held decreased 75.86% compared to the previous period and now represents 0.0003% of the total position.
      1Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:11
      ARKG Investment Tracker position change: Decreased position in Veeva by 837 shares, the number of shares held decreased 0.92% compared to the previous period and now represents 1.68% of the total position.
      92Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:11
      ARKG Investment Tracker position change: Decreased position in 10x Genomics, Inc. by 26,469 shares, the number of shares held decreased 0.92% compared to the previous period and now represents 3.37% of the total position.
      13Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:11
      ARKG Investment Tracker position change: Decreased position in Pacific Biosciences of California by 102,268 shares, the number of shares held decreased 0.82% compared to the previous period and now represents 1.89% of the total position.
      4.01K3
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:11
      ARKG Investment Tracker position change: Decreased position in Twist Bioscience Corp by 21,582 shares, the number of shares held decreased 0.92% compared to the previous period and now represents 8.47% of the total position.
      103Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:11
      ARKG Investment Tracker position change: Decreased position in Intellia Therapeutics by 27,918 shares, the number of shares held decreased 0.92% compared to the previous period and now represents 3.5% of the total position.
      5Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:11
      ARKG Investment Tracker position change: Decreased position in Regeneron Pharmaceuticals by 126 shares, the number of shares held decreased 0.89% compared to the previous period and now represents 0.93% of the total position.
      169Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:11
      ARKG Investment Tracker position change: Decreased position in Schrodinger Inc. by 21,897 shares, the number of shares held decreased 0.92% compared to the previous period and now represents 4.01% of the total position.
      1Comment
      Report
    • empty
      No following yet
       
       
       
       

      Most Discussed

       
       
       
       
       

      Terms and Conditions·Privacy Policy

      Company: TTMF Limited. Tech supported by Xiangshang Yixin.

      Email：uservice@ttm.financial